Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer

Purpose: Serous adenocarcinoma is a rare, aggressive histologic subtype of endometrial cancer with a high rate of recurrence and a poor prognosis. The optimal adjuvant treatment for early-stage patients is unclear. Our objective was to evaluate the outcomes of stage IA serous endometrial cancers onl...

Descripción completa

Detalles Bibliográficos
Autores principales: Donovan, Elysia, Reade, Clare J, Eiriksson, Lua R, Pond, Gregory R, Arora, Nikita, Elit, Lorraine, Memon, Sadaf, Voruganti, Sachi, Patel, Maltibehn, Jimenez, Waldo, John, Mazurka, Kong, Iwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Obstetrics/Gynecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267614/
https://www.ncbi.nlm.nih.gov/pubmed/30524915
http://dx.doi.org/10.7759/cureus.3387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267614/
https://www.ncbi.nlm.nih.gov/pubmed/30524915
http://dx.doi.org/10.7759/cureus.3387

Ejemplares similares